Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Apr 15, 2025

Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
VLS
Vita Life Sciences
AU$1.82-3.4%-22.2%AU$100.9mn/aPE11.5xn/a5.5%
EZZ
EZZ Life Science Holdings
AU$1.508.7%76.5%AU$70.8mAU$5.15PE7.8xE13.4%2.7%
CTE
Cryosite
AU$0.805.3%13.6%AU$38.8mn/aPE21.2xn/a2.5%
CSL
CSL
AU$244.10-0.7%-11.1%AU$118.2bAU$314.03PE27.4xE13.1%1.7%
CUV
Clinuvel Pharmaceuticals
AU$10.760.9%-29.0%AU$537.4mAU$24.63PE13.9xE6.9%0.5%
MVP
Medical Developments International
AU$0.480%-11.8%AU$54.6mAU$2.11PS1.4xE95.8%0%
ACR
Acrux
AU$0.022-12.0%-62.7%AU$9.0mn/aPS11.2xE106.9%0%
VIT
Vitura Health
AU$0.077.7%-57.6%AU$46.4mn/aPE23.8xn/a0%